My Portfolio
My Watchlists
Profile & Performance
Smart Portfolio
Find & Follow Experts
Top Lists
Top Experts
Make Better, Data Driven Investment Decisions
TipRanks tools are all you need to make data-driven investment decisions, conduct comprehensive stock research, find new investment ideas, analyze your portfolio, and follow the best-performing Wall Street experts.
About Us
Plans & Pricing
Clovis Oncology (CLVS)
NASDAQ:CLVS
CLVS nasdaq
United States
Clovis Oncology

Clovis Oncology Stock Investors

Based on 490,174 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold CLVS
On average, investors allocate 2.26% of their portfolios to CLVS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 490,174 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CLVS

>0.1%
Last 7
Days
>0.1%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CLVS, out of 490,174 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CLVS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Closed
0.00%
$4.36
Increased
0.04%
$4.84
Closed
0.00%
$4.45
Opened
1.82%
$4.41
Closed
0.00%
$4.69
Closed
0.00%
$4.54
Closed
0.00%
$4.97
Opened
1.69%
$4.97
Based on the activity of 42,088 investors who made their portfolios public
The table shows changes in CLVS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CLVS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
AMRNAmarin
4.22%
-2.35%
1.23%
$2.04B
Healthcare
EDITEditas Medicine
4.09%
-0.64%
4.19%
$2.60B
Healthcare
SRPTSarepta Therapeutics
4.57%
-0.02%
-0.02%
$6.72B
Healthcare
BLUEBluebird Bio
2.23%
-3.07%
-4.80%
$1.41B
Healthcare
AXSMAxsome Therapeutics
9.01%
-2.45%
-0.11%
$1.51B
Healthcare
ATRAAtara Biotherapeutics
4.07%
-4.52%
-11.29%
$1.28B
Healthcare
TLRYTilray
6.28%
-0.18%
-4.15%
$4.57B
Basic Materials
INOInovio Pharmaceuticals
4.07%
-1.03%
-5.03%
$1.48B
Healthcare
MUMicron
6.36%
-0.47%
1.45%
$75.71B
Technology
NOKNokia
5.82%
-0.52%
-2.31%
$33.21B
Technology
Based on the activity of 490,174 active portfolios
Open your Smart Portfolio

CLVS Investor Analysis

CLVS investors under 35

Under 35

>0.1%
Last 30 days
Holdings Change
19.4%
of CLVS holders
are under 35
Average Segment Performance
Monthly Return1.67%
Beta1.27
Dividend Yield6.01%
CLVS investors between 35–55

Between 35–55

>0.1%
Last 30 days
Holdings Change
44.8%
of CLVS holders
are between 35–55
Average Segment Performance
Monthly Return1.81%
Beta5.88
Dividend Yield22.65%
CLVS investors over 55

Over 55

>0.1%
Last 30 days
Holdings Change
35.8%
of CLVS holders
are over 55
Average Segment Performance
Monthly Return1.80%
Beta1.33
Dividend Yield6.03%
Overview of age group and performance of CLVS stock investors
See who invests in CLVS according to age group and performance.

Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
TSE:TRYPTryp Therapeutics Inc
INNPFInnoCan Pharma
PHRRFNPharmaTher
JUVAFJuva Life, Inc.
KRBPKiromic Biopharma

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis